Michael Gelband’s Sharecare, Inc. Class A Common Stock SHCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-705,122
Closed -$1M 2196
2024
Q3
$1M Buy
+705,122
New +$978K 0.01% 971
2024
Q1
Sell
-3,892,046
Closed -$4.2M 2063
2023
Q4
$4.2M Buy
3,892,046
+501,919
+15% +$515K 0.03% 379
2023
Q3
$3.19M Buy
+3,390,127
New +$4.05M 0.03% 507
2023
Q1
Sell
-373,379
Closed -$597K 2202
2022
Q4
$597K Buy
373,379
+138,197
+59% +$256K 0.01% 1111
2022
Q3
$447K Sell
235,182
-180,890
-43% -$317K 0.01% 1405
2022
Q2
$657K Sell
416,072
-204,842
-33% -$503K 0.01% 1259
2022
Q1
$1.53M Buy
620,914
+258,659
+71% +$850K 0.02% 910
2021
Q4
$1.63M Buy
+362,255
New +$2.33M 0.02% 847

Other funds holding SHCR

Michael Gelband's SHCR Position: Q4 2024 in Review

Michael Gelband sold out of Sharecare, Inc. Class A Common Stock (SHCR) in Q4 2024, closing a stake of 705,122 shares — an estimated $1M sold.

Michael Gelband first reported a position in SHCR in Q4 2021 and held it in 8 quarters. The position peaked at $4.2M in Q4 2023. 1 fund tracked by Wall St. Rank holds SHCR as of Q4 2024.

  • Michael Gelband reported no remaining Sharecare, Inc. Class A Common Stock position as of Q4 2024 after selling out during the quarter.
  • Michael Gelband sold 705,122 Sharecare, Inc. Class A Common Stock shares in Q4 2024, an estimated $1M.
  • Michael Gelband first reported a position in Sharecare, Inc. Class A Common Stock in Q4 2021 and held it in 8 quarters.
  • Michael Gelband's Sharecare, Inc. Class A Common Stock position peaked at $4.2M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Sharecare, Inc. Class A Common Stock as of Q4 2024.

Based on ExodusPoint Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.